Stay updated on VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial page.

Latest updates to the VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial page
- Check3 days agoChange DetectedLocations were updated to add new sites and revise the study's recruitment locations, including US locations and Región de Valparaíso (Chile). The page revision changed from v3.3.2 to v3.3.3.SummaryDifference1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a note clarifying that PubMed publications are automatically filled from PubMed and may not all relate to the study. Updated page revision to v3.3.2.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page no longer displays the government funding lapse notice, which is an administrative update and does not affect the trial details, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check61 days agoChange DetectedThe new screenshot shows minor UI/layout tweaks and small copy edits; core study information such as eligibility criteria, interventions, outcomes, and listed locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check82 days agoChange DetectedUpdated operating-status notice and v3.2.0 release; removed two carcinoma terms and old v3.1.0 tag.SummaryDifference3%

- Check89 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial page.